Skip to main content
PMC home page
NeuroImage : Clinical logoLink to NeuroImage : Clinical
. 2014 Apr 13;4:649–658. doi: 10.1016/j.nicl.2014.04.005

Characterizing the microstructural basis of “unidentified bright objects” in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis

Thibo Billiet a,b,c,d,*, Burkhard Mädler e, Felice D'Arco f, Ronald Peeters b,d, Sabine Deprez a,b,c,d, Ellen Plasschaert g,h, Alexander Leemans i, Hui Zhang j, Bea Van den Bergh k,l, Mathieu Vandenbulcke d,m,n, Eric Legius g,h, Stefan Sunaert a,b,c,d, Louise Emsell a,b,c,d
PMCID: PMC4053637  PMID: 24936416

Abstract

Introduction

The histopathological basis of “unidentified bright objects” (UBOs) (hyperintense regions seen on T2-weighted magnetic resonance (MR) brain scans in neurofibromatosis-1 (NF1)) remains unclear. New in vivo MRI-based techniques (multi-exponential T2 relaxation (MET2) and diffusion MR imaging (dMRI)) provide measures relating to microstructural change. We combined these methods and present previously unreported data on in vivo UBO microstructure in NF1.

Methods

3-Tesla dMRI data were acquired on 17 NF1 patients, covering 30 white matter UBOs. Diffusion tensor, kurtosis and neurite orientation and dispersion density imaging parameters were calculated within UBO sites and in contralateral normal appearing white matter (cNAWM). Analysis of MET2 parameters was performed on 24 UBO–cNAWM pairs.

Results

No significant alterations in the myelin water fraction and intra- and extracellular (IE) water fraction were found. Mean T2 time of IE water was significantly higher in UBOs. UBOs furthermore showed increased axial, radial and mean diffusivity, and decreased fractional anisotropy, mean kurtosis and neurite density index compared to cNAWM. Neurite orientation dispersion and isotropic fluid fraction were unaltered.

Conclusion

Our results suggest that demyelination and axonal degeneration are unlikely to be present in UBOs, which appear to be mainly caused by a shift towards a higher T2-value of the intra- and extracellular water pool. This may arise from altered microstructural compartmentalization, and an increase in ‘extracellular-like’, intracellular water, possibly due to intramyelinic edema. These findings confirm the added value of combining dMRI and MET2 to characterize the microstructural basis of T2 hyperintensities in vivo.

Keywords: Myelin water imaging (MWI), Diffusion tensor imaging (DTI), Diffusion kurtosis imaging (DKI), Neurite orientation dispersion and density imaging (NODDI), Neurofibromatosis type 1 (NF1), Unidentified bright objects (UBOs)

Highlights

  • •

    We examine MRI white matter T2-weighted hyperintense lesions, “UBOs” in NF1.

  • •

    Myelin water and intra- and extracellular water fractions are unchanged in UBOs.

  • •

    Diffusivity is higher, while mean kurtosis and neurite density are lower in UBOs.

  • •

    The combined measures suggest that UBOs may arise from intramyelinic edema.

  • •

    Combining diffusion MRI and multi-exponential T2 relaxation has added value.

1. Introduction

Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder, with a prevalence of approximately 1 in 2700 newborns (Evans et al., 2010). The disorder is characterized by multiple café-au-lait spots, axillary or inguinal freckling, iris Lisch nodules, distinctive osseous lesions and tumors of the nervous system, such as neurofibromas and optic pathway gliomas. In addition to these clinical features, cognitive dysfunction is the most common complication of NF1. Approximately 80% of NF1 children experience moderate to severe impairment in one or more areas of cognitive functioning (Hyman et al., 2005; Krab et al., 2008).

1.1. Unidentified bright objects

NF1 is associated with a number of magnetic resonance (MR) abnormalities, including volumetric change in both white matter (WM) and gray matter (GM) (Moore, B.D. 3rd et al., 2000; Cutting et al., 2000; Steen et al., 2001; Greenwood et al., 2005). In addition to these general changes, hyperintense foci, termed “unidentified bright objects” (UBOs) or T2 hyperintensities are readily detected on T2-weighted MRI scans of children and adolescents with the disorder. Such UBOs are typically found in the cerebellum (dentate nuclei, middle cerebellar peduncles, cerebellar deep white matter), brainstem, basal ganglia and thalami (Itoh et al., 1994; Van Es et al., 1996; Griffiths et al., 1999). Fig. 1 shows some examples.

Fig. 1.

Fig. 1

Open in a new tab

Examples of unidentified bright objects (UBOs) as seen on T2-weighted FLAIR images of NF1 children. A: Bilateral basal ganglia (top arrows) and hypothalamus (bottom arrows). B: splenium of corpus callosum. C: Globus pallidus. D: Cerebellar white matter. E: Cerebral peduncle. F: Junction of pons and mesencephalon. Note: in this study we only examined white matter UBOs.

UBOs have been described as hamartomas1 (Braffman et al. 1988), regions of abnormal myelination (Smirniotopoulos and Murphy 1992) or heterotopias2 (Bognanno et al. 1988). However, as NF1 is rarely lethal, to date only one histological experiment has been conducted to assess UBO microstructure (DiPaolo et al., 1995). In this study, vacuoles of between 5 and 100 µm were found in the myelin sheath, suggesting intramyelinic edema. No evidence of any inflammatory reaction or demyelination was found and axonal loss was excluded. Furthermore, the white matter expressed hypocellularity and glial cell proliferation.

Although UBOs may be transient and are considered benign, some persist into adulthood and there is increasing evidence correlating their presence with cognitive dysfunction (B.D. Moore et al., 1996; Goh et al., 2004; Hyman et al., 2007; Feldmann et al., 2010; Piscitelli et al., 2012). Understanding the pathophysiological substrate of UBOs may provide a basis from which to identify which UBOs are transient, how they respond to pharmacological treatments and how they relate to the risk of cognitive complaints during childhood and adolescence.

1.2. In vivo assessment of UBO microstructure using diffusion MRI and multi-exponential T2 relaxation

Diffusion magnetic resonance imaging (dMRI) (Le Bihan et al., 1986) can be used to investigate UBOs in vivo. dMRI relates the dispersion of water molecules within tissue over a short interval of time (typically in the order of 10-2 s) to microstructural features reflecting cellularity, membrane density and neurite orientation. In (over-) simplified terms, water moving most freely, such as in extra-axonal spaces, displays Gaussian diffusion, while water restricted within cells, displays non-Gaussian diffusion. A number of different dMRI models are able to quantify these two types of diffusion, namely diffusion tensor imaging (DTI) (Basser et al., 1994a; Basser, 1995), diffusion kurtosis imaging (DKI) (Jensen and Helpern, 2010) and neurite orientation dispersion and density imaging (NODDI) (Zhang et al., 2012), and are summarized in Table 1.

Table 1.

Summary of MRI techniques, models and derived parameters used in the present study.

Imaging technique Model Measure Abbreviation Measure relates to Scale
Diffusion MRI (dMRI) DTI Fractional anisotropy FA Presence of preferred direction of diffusion (i.e. tissue anisotropy) 0–1 (0 = most isotropic, 1 = most anisotropic)
Mean diffusivity MD Amount of isotropic diffusion (i.e. not bounded by membranes, e.g. in CSF) Continuous increasing value = increasing amount of diffusion
Axial diffusivity AD Amount of isotropic diffusion along direction of maximal diffusion Continuous increasing value = increasing amount of diffusion
Radial diffusivity RD Amount of isotropic diffusion perpendicular to direction of maximal diffusion Continuous increasing value = increasing amount of diffusion
DKI Mean kurtosis MK Presence of compartments that do not have a Gaussian diffusion profile (i.e. bounded by membranes) Continuous increasing value = more compartmentalization
NODDI Neurite density index NDI Density of axons and dendrites based on intracellular diffusion 0–1 (0 = most extracellular diffusion, 1 = most intracellular diffusion)
Orientation dispersion index ODI Dispersion of axons and dendrites in the intracellular compartment 0–1 (0 = well-aligned neurites, 1 = highly dispersed neurites)
Fraction of isotropic compartment FISO Cerebrospinal fluid (isotropic Gaussian diffusion) 0–1 (0 = no CSF-like fluid, 1 = most CSF-like fluid)
Multi-exponential T2 relaxation (MET2) MET2 Myelin water fraction MWF Myelin content 0–1 (0 = least myelin, 1 = most myelin)
Intra- and extracellular water fraction IEWF Water molecules in and between axons (or having similar properties) 0–1 (0 = no intra- or extracellular water, 1 = mostly intra- and extracellular water)
Geometric mean T2 time IEW-gmT2 Intra- and extra-axonal mobility of water molecules (e.g. long T2 time = high mobility) Continuous increasing value = more loosely bound water molecules
Open in a new tab

Previous studies using simple dMRI and DTI have reported elevated apparent diffusion coefficient (ADC) in T2-hyperintense lesions compared to NAWM in patients (Alkan et al., 2005; Tognini et al., 2005) and controls (Eastwood et al., 2001; Alkan et al., 2005; Tognini et al., 2005; van Engelen et al., 2008) and significantly decreased fractional anisotropy (FA) values in UBO sites compared to NAWM (Zamboni et al., 2007; Ferraz-Filho et al., 2012a; Ferraz-Filho et al., 2012b; Filippi et al., 2012). Neither DKI nor NODDI has previously been used to investigate UBOs.

Multi-exponential T2 relaxation (MacKay et al., 1994; MacKay et al., 2006) is a complementary MRI technique that distinguishes the MR signal arising from different water pools based on T2 relaxation. Typically three water peaks can be identified in the so-called T2 distribution. In normal human white matter, and in a 3 Tesla magnetic field, the water that is trapped between the myelin bilayers exhibits a short T2 relaxation time of around 20 ms, whereas intra- and extracellular water relaxes at an intermediate rate of around 80 ms (MacKay et al., 1994; Whittall et al., 1997; Webb et al., 2003). The first peak in the T2 distribution is therefore attributable to myelin water, while the second peak (around 80 ms) represents combined intra- and extracellular water. CSF has T2 values in the order of seconds.

A summary of the measures that can be derived from dMRI and MET2 is provided in Table 1, and a more detailed overview is provided as Supplementary material (SM1).

1.3. Aim of present study

Although findings from DTI metrics are suggestive of altered tissue microstructure in UBO regions, the lack of specificity of measures derived from these techniques means that the exact nature of the histopathological changes arising in UBOs remains elusive. The aim of the present study therefore, was to use two novel, advanced white matter imaging approaches: MET2 and DKI/NODDI, in addition to DTI, to refine our understanding of the microstructural basis of UBOs. By extension, a further aim was to demonstrate the utility of combining these techniques to advance our understanding of T2 hyperintensities arising in other pathologies and advancing age.

2. Materials & methods

2.1. Subjects

Seventeen NF1 patients with UBOs (7 girls (age 13 ± 3 years), 10 boys (age 12 ± 3 years)) underwent an MRI scan. Subjects were recruited from the Leuven multidisciplinary neurofibromatosis clinic and the multidisciplinary NF1-outpatient clinic of the Erasmus MC-Sophia Children's Hospital in Rotterdam. The study was approved by the local Ethical Commission and conducted in accordance with the Declaration of Helsinki.

2.2. Data acquisition

Imaging data were acquired using a 3 T MR scanner (Achieva; Philips, Best, the Netherlands) and a 32-channel phased-array head coil.

Multi-slice T2-weighted FLAIR images were acquired to identify UBOs. Acquisition parameters were TR/TI = 11,000 ms/2800 ms, TE = 120 ms, 25 slices, and thickness 4 mm.

A spin-echo echo-planar imaging diffusion-weighted scheme was obtained consisting of three b-values (700, 1000 and 2800 s/mm2) acquired along 25, 40 and 75 uniformly distributed directions, respectively (Poot et al., 2010). Constant scan parameters were TR/TE = 7800 ms/90 ms, 50 slices, voxel size 2.5 × 2.5 × 2.5 mm3, parallel imaging factor 2. Each diffusion-weighted acquisition was complemented with a gradient-free image (b = 0) and seven additional b = 0 images were acquired.

For MET2 analysis, a 3D GraSE multi-echo sequence was used (Maedler and MacKay, 2007; Prasloski et al., 2012b). The scan included 32 echoes with a first echo time of 10 ms and a ?TE of 10 ms (TE = 10 ms, 20 ms, …, 320 ms) and EPI read-out factor of 3, TR = 800 ms, 32 mid-axial slices and voxel size 1 × 1 × 2 mm3.

2.3. Data analysis

2.3.1. T2-weighted FLAIR

An experienced radiologist (FD' A) identified white matter UBOs on T2-weighted FLAIR images. We excluded regions of bilateral T2-hyperintensities from the analysis. The T2-weighted FLAIR images were then resampled to 2.5 mm slice thickness and regions of interest (ROIs) were manually delineated around sites of white matter hyperintensities and the contralateral normal-appearing white matter (cNAWM).

2.3.2. dMRI

All datasets were visually inspected by looping through the DWIs in all three orthogonal views (axial, sagittal, coronal). Datasets with obvious artifacts (e.g. signal dropout, gross geometric distortion, bulk motion) were excluded. The suitable datasets were then corrected for motion-induced and eddy current induced geometric distortions with appropriate reorientation of the b-matrix using the ExploreDTI Toolbox (Leemans, 2009; Leemans and Jones, 2009). Next, the resulting DWIs were fitted to the DTI model (Basser et al., 1994b), the DKI model (Jensen and Helpern, 2010) and the NODDI model (Zhang et al., 2012). Mean diffusivity (MD), radial diffusivity (RD), axial diffusivity (AD) and fractional anisotropy (FA) were estimated from the diffusion tensor, and the kurtosis tensor yielded mean kurtosis (MK). Estimates of neurite density index (NDI), orientation dispersion index (ODI) and the isotropic fraction (FISO) were obtained with the NODDI toolbox3. The resampled T2-weighted FLAIR images were registered to the FA image using ANTS (Friston et al., 2007; Avants et al., 2008) with diffeomorphic transformations and a pure cross correlation similarity metric. The same transformation was applied to all UBO–cNAWM pairs, which were then used as masks on the dMRI parameter maps. All parameter values in the UBO and cNAWM regions of interest were averaged, respectively.

2.3.3. Multi-exponential T2 relaxation

The multi-echo data was first visually checked for motion artifacts and datasets with a blurred first echo image were discarded. The resampled T2-weighted FLAIR data were then registered with the first echo image, using the same approach as described before. This transformation was then applied on all ROIs. Next, decay curves of voxels inside each ROI were averaged and T2 relaxation distributions were calculated using a regularized non-negative least squares algorithm (Whittall and Mackay, 1989), correcting for non-ideal refocusing pulse flip angles (Prasloski et al., 2012a).

Inside each ROI, the myelin water fraction (MWF) was defined as the area underneath the T2 distribution between 10 and 35 ms relative to the total area. Intra- and extracellular water fraction (IEWF) was obtained as the relative area fraction between 35 and 220 ms. The geometric mean T2 time (IEW-gmT2) was calculated as described in Whittall et al. (1997) (see Supplementary material SM1 for further information about these parameters).

2.4. Statistical analysis

After obtaining average parameter values in all UBOs and cNAWM ROIs, we assessed whether the data was normally distributed. For each UBO–cNAWM pair and each parameter, an estimate of the effect size was calculated as the difference of UBO and cNAWM values divided by their mean. Next the Lilliefors test was applied on the resulting effect sizes of each parameter. As normality could not be guaranteed for all parameters, a non-parametric testing was used for further statistical analysis. For each parameter, UBO and cNAWM parameter values were therefore compared using a paired Wilcoxon signed ranks test, i.e. parameter of interest in UBO 1 vs. cNAWM 1, parameter of interest in UBO 2 vs. cNAWM 2, etc. This analysis was performed in MATLAB (MathWorks, Natick, MA) using the signrank function. Resulting p-values were then corrected for multiple comparisons, adopting a 5% false discovery rate (FDR) criterion. Corrected values were deemed significant if p < 0.05.

3. Results

As can be seen from Table 2, from the 17 subjects, 30 UBO–cNAWM pairs were obtained for dMRI analysis, of which 24 also yielded sufficient MET2 data quality and were located inside the FOV of the 3D GraSE sequence. An example of the evaluated parameter maps is displayed in Fig. 2.

Table 2.

Subject characteristics and UBO number and locations.

Subject Gender Age (years) UBO–cNAWM pairsa Locationb
1 F 16.1 1 CCS
2 M 10.1 1 CblP
3 F 11.7 1 CWM
4 F 12.7 2 CblP, CP
5 F 12.1 4 (1) CWM, CWM, pons, CP
6 F 15.8 1 AC
7 F 9.5 4 (1) CS, CP, bulb, CWM
8 M 9.6 2 MES, CWM
9 F 16.1 1 CP
10 M 17.2 3 CWM, pons, CCS
11 M 12.2 2 MES, CWM
12 M 9.4 1 CWM
13 M 9.2 1 CWM
14 M 14.7 1 CP
15 M 8.7 1 CWM
16 M 14.5 1 CWM
17 M 15.4 3 Bulb, CWM, CblP
Open in a new tab

F, female; M, male; CCS = splenium of corpus callosum; CblP = cerebellar peduncle; CWM = cerebellar white matter; CP = cerebral peduncle; AC = anterior commissure; CS = centrum semiovale; MES = mesencephalon; bulb = bulbus.

a

If different for MET2 and dMRI analysis, the number in between brackets indicates the number of UBO-cNAWM pairs for MET2 analysis.

b

Underlined locations were not available for MET2 analysis.

Fig. 2.

Fig. 2

Open in a new tab

Example (native space) parameter maps of a UBO in the splenium of the corpus callosum. Red arrows indicate the UBO in the T2-weighted FLAIR image and in parameter maps for which this study found significant results. MWF: myelin water fraction; IEWF: intra- and extracellular water fraction; IEW-gmT2: geometric mean T2 time of intra- and extracellular water (s); FA: fractional anisotropy; RD: radial diffusivity (mm2 s-1); AD: axial diffusivity (mm2 s-1); MD: mean diffusivity (mm2 s-1); MK: mean kurtosis (no unit); NDI: neurite density index; ODI: orientation dispersion index: FISO: isotropic fraction. Color bars indicate the scalar value range.

3.1. dMRI results

Fig. 3 summarizes the results from the analysis of diffusional and kurtosis estimates. Compared to regions of cNAWM, T2-hyperintensities showed both increased AD (FDR — p = 0.0061) and RD (FDR — p = 0.0066), leading to an increase of MD (FDR — p = 0.0041). There appeared to be less anisotropy in UBOs than in cNAWM as FA was significantly decreased (FDR — p = 0.021). Furthermore, a significantly decreased MK (FDR — p = 0.0012) in UBOs compared to cNAWM was found, indicating that non-Gaussian diffusion was less present in UBOs than in cNAWM.

Fig. 3.

Fig. 3

Open in a new tab

Boxplot representation (box containing median and 25th and 75th percentiles) of dMRI and MET2 parameter values. The left side of each panel (dark box) corresponds with values in cNAWM, the right side (light box) with values in contralateral UBOs. Dashed gray lines connect values from one UBO–cNAWM pair. MWF = myelin water fraction; IEWF = intra- and extracellular water fraction; IEW-gmT2 = geometric mean T2 time of the intra- and extracellular water (s); FA = fractional anisotropy; RD = radial diffusivity (mm2s-1); AD = axial diffusivity (mm2s-1); MD = mean diffusivity (mm2s-1); MK = mean kurtosis (no unit); NDI = neurite density index; ODI = orientation dispersion index of neurites; FISO = isotropic fraction.

The NODDI model resulted in reduced NDI in UBOs (FDR — p = 0.014) with no significant alterations in FISO (FDR — p = 0.51) or in ODI (FDR — p = 0.88).

3.2. Multi-exponential T2 relaxation results

Fig. 4 illustrates typical T2 distributions of three UBOs and their cNAWM. Distributions for the remaining UBOs can be found in the Supplementary material SM2. Both figures illustrate the water fraction of the different water pools and the mean T2 of the IEW peak. The statistical results illustrated in Fig. 3 show that the IEW peak in UBOs appears to be shifted to longer T2 relaxation values (IEW-gmT2, FDR — p = 0.0014). MWF (FDR — p = 0.35) and IEWF (FDR — p = 0.86) did not differ significantly between UBOs and cNAWM.

Fig. 4.

Fig. 4

Open in a new tab

Typical T2 distribution of UBO (red) and cNAWM (blue). Red and blue vertical dashed lines indicate the IEW-gmT2 of UBO and cNAWM, respectively. The intra- and extracellular water (IEW) peak in the UBO shows a shift towards longer T2 times as illustrated by the red arrows. Vertical dashed lines in black indicate the integration interval for the IEW peak. Left: cerebral peduncle; middle: splenium of corpus callosum; right: cerebellar white matter.

For clarity, the above results are summarized in Table 3.

Table 3.

Results of diffusion MRI and multi-exponential T2 relaxation parameters evaluated in UBOs and compared with cNAWM. FA = fractional anisotropy (%); MD = mean diffusivity (mm2s-1); AD = axial diffusivity (mm2s-1); RD = radial diffusivity (mm2s-1); MK = mean kurtosis (no unit); NDI = neurite density index (%); ODI = orientation dispersion index of neurites (%); FISO = isotropic fraction (%); MWF = myelin water fraction (%); IEWF = intra- and extracellular water fraction (%); IEW-gmT2 = geometric mean T2 time of the intra- and extracellular water (s). An asterisk next to the FDR-corrected p-values indicates significance at 95% confidence level.

Type of imaging Parameter Direction of significant change (UBO compared to cNAWM) FDR-corrected p-value (FDR-p)
DTI FA ? 0.021*
MD ? 0.0041*
AD ? 0.0061*
RD ? 0.0066*
DKI MK ? 0.0012*
NODDI NDI ? 0.014*
ODI – 0.88
FISO – 0.51
MET2 MWF – 0.35
IEW-gmT2 ? 0.0014*
IEWF – 0.86
Open in a new tab

4. Discussion

To our knowledge, this was the first study to investigate non-Gaussian diffusion and multi-exponential T2 relaxation parameters in children with NF1. We demonstrated a lower MK in UBOs compared to cNAWM using DKI, and a decreased neurite density (NDI) in UBOs with unchanged neurite orientation dispersion (ODI) and isotropic fraction (FISO) using NODDI. The myelin water fraction and IEWF were also unchanged. In contrast, increased T2 relaxation values of the intra- and extracellular water (IEW-gmT2) in UBOs appeared to be the main cause of T2 hyperintensities. We also confirmed previous findings of decreased fractional anisotropy (FA) and detected increased axial, radial and mean diffusivity (AD, RD and MD, respectively) in UBOs.

4.1. Which microstructural changes may be occurring in the white matter UBOs?

The myelin water fraction was not altered significantly, suggesting more or less intact myelin layers. This is in line with previous histological findings (DiPaolo et al., 1995), although differences in myelin water content in living and post-mortem tissue mean that findings from our respective studies cannot be compared equivalently. Margariti et al. (2007) hypothesized that decreased magnetization transfer ratio (MTR) in UBOs represented hypomyelination in their study of NF1 patients and healthy controls. However, decreased MTR may also relate to an increase in edema or inflammation, without demyelination (Stanisz et al., 2004; Laule et al., 2007a; Vavasour et al., 2011). Given the unaltered MWF found in the present study, our results favor a hypothesis of edema formation. Further evidence comes from our observation of prolonged IEW-gmT2. This suggests that the intra- and extracellular matrix differs substantially between UBO regions and cNAWM, which would be expected in the case of edema or inflammation (Stanisz et al., 2004). Other possible mechanisms of this prolonged IEW-gmT2 could include glial cell proliferation or reduced exchange between intra- and extracellular water.

4.2. Could UBOs be caused by intramyelinic edema?

Having established a plausible hypothesis for edema, is it possible to deduce in which microstructural compartment it is arising? In intramyelinic edema vacuoles are formed in between the myelin layers due to splitting at the intraperiod line. There is some evidence from previous work and our findings that supports the presence of intramyelinic edema in UBOs. For example: prolonged T2 relaxation times have been found in a biexponential T2 relaxation study of intramyelinic edema in cats (Barnes et al., 1987) and a three-pool MET2 model of intramyelinic edema in rats (Harkins et al., 2013) also yielded a distinct long-T2 reservoir. The difference between the latter and our study is mainly that we made no assumptions about the number of water peaks to be found. Water compartments with similar but distinct T2 times may therefore be expressed as a single peak having a prolonged T2 time. In the case of intramyelinic edema, this may explain why most of our UBO samples showed prolonged T2 rather than distinct long-T2 peaks.

Diffuse WM lesions of phenylketonuria (PKU) patients are thought to be expressions of hypomyelination or intramyelinic edema, depending on treatment status (Anderson and Leuzzi, 2010). Sirrs et al. found that diffuse white matter lesions observed in phenylketonuria (PKU) patients also exhibit prolonged T2 values, in the form of an additional reservoir (Sirrs et al., 2007).

In addition to PKU or intramyelinic edema models, prolonged T2 values have also been observed in multiple sclerosis lesions, (Armspach et al., 1991) in which the prolongation could be linked to vacuolization, increases in the amount of extracellular water or reduced exchange between intra- and extracellular water (Laule et al., 2007b; Laule et al., 2007c).

These multiple pathological mechanisms underlying prolonged T2 time complicate the interpretation of the origin of the prolonged IEW-gmT2 we find in UBOs based on MET2 alone.

4.3. Can we learn more by considering the diffusion measures?

In agreement with previous studies, decreased FA and increased MD were found in UBOs compared to cNAWM, suggesting altered tissue microstructure. Elevated levels of both AD and RD reveal that the increase in MD is not related to only one or selective directions of diffusion. The elevated mean diffusivity levels are in contrast with what is found in PKU, where generally MD is lower in diffuse WM lesions than in NAWM of healthy controls (Dezortova et al., 2001; Phillips et al., 2001; Leuzzi et al., 2007; Vermathen et al., 2007). However, some authors have argued that lower MD in PKU lesions is more probably due to cytotoxic edema (Dezortova et al., 2001; Phillips et al., 2001) or accumulation of hydrophilic metabolites (Leuzzi et al., 2007). Notably, in Maple Syrup Urine Disease (MSUD) brainstem lesions with reduced ADC are observed, which is not the case in similarly located NF1 UBOs. We might expect that intramyelinic vacuoles would lead to increased diffusivity levels as we found in this study. In any case, if intramyelinic edema were to be present in NF1, PKU and MSUD lesions, there could be differences (perhaps vacuole size or presence of debris) that may be revealed using combined MET2 and dMRI methods.

The DKI model additionally indicated alterations in tissue compartments displaying non-Gaussian diffusion. However, as with DTI parameters, the interpretation of kurtosis estimates in isolation is limited. The NODDI framework therefore may allow further interpretation of DTI and DKI changes by incorporating a three-compartment biophysical tissue model.

Reduced NDI and unaltered ODI in UBOs suggest that the reduced FA is mainly caused by a lower neurite density (as defined by the NODDI model) and not so much by increased dispersion of neurite orientations. This could be explained by axonal loss. However, as the MWF and IEWF from MET2 analysis did not change in the UBOs in our study, axonal loss is unlikely to be the primary determinant of reduced neurite density. Rather, the decreased NDI could arise from an increased distance between axons, for example, due to edema.

These observations make it difficult to conclude that intramyelinic edema is present. However, edema arising in the extracellular space is less likely. If that were the case, and given the Gaussian diffusion profile of the extracellular space, FISO would be expected to increase, which we did not observe. Intramyelinic edema therefore remains a possible hypothesis.

This combined analysis illustrates the complementary nature of dMRI and MET2 when it comes to evaluating T2 hyperintensities such as UBOs. MET2 analysis alone is not able to distinguish whether an increase in IEW-gmT2 is more related to changes in the intra- or extracellular water compartment. The NODDI analysis offers an indication of disparity between intra- and extracellular compartments, based on differences in diffusional properties. On the other hand, dMRI measures are less specific to myelination than the myelin water fraction from MET2 analysis.

4.4. Methodological considerations

This study benefits from the application of two advanced, novel MR based techniques, which has allowed us to investigate UBO microstructure in vivo, to a degree not previously possible using conventional imaging techniques. However, there remain a number of limitations that should be addressed.

Firstly, this is a small-scale exploratory study and the findings require confirmation in a larger sample.

Secondly, as with all studies employing image registration and manually defined ROIs, errors arising from these techniques cannot be ruled out. Of particular importance in this study is the issue of partial volume, where contamination from CSF may influence the results. To minimize this, we avoided delineating ROIs near to the ventricles. We also used advanced diffeomorphic registration to limit registration errors. Another issue relates to the ROI definition itself. We used the well-defined boundary on T2-weighted FLAIR to isolate the UBOs, however, it is possible that microstructural changes extend beyond this region (Mizukoshi et al., 2009). We also used cNAWM as a control region, however, it is impossible to precisely define an equivalent contralateral region, which itself may be subject to other underlying disease-related tissue changes that are not visually appreciable using the imaging method used in this study.

A related issue concerns differences in the size and location of ROIs. We used an average measure from each contributing voxel within an ROI. However, the variance of these measures will be influenced by the size of the ROI delineated. As each ROI was defined by the size of the UBO, this issue was an unavoidable feature of our analysis approach. Regarding the location of the UBOs, in our interpretation we assume that all UBOs and cNAWM have the same underlying microstructure irrespective of location. However, this does not account for known variability in WM microstructure throughout the brain or potential differences between UBOs. For example, some UBOs are transient and others remain. We addressed this in part by limiting our analysis to UBOs located in WM, however, as this is a cross-sectional study, we do not know which, if any of the UBOs included for investigation will disappear over time. Rescanning the patients included in this study in the future will therefore be highly informative.

Finally, although the MRI based measures utilized in this study are directly influenced by tissue microstructure, they remain indirect metrics based on simplified mathematical models and imperfect imaging techniques. While the inclusion of non-Gaussian diffusion in the DKI and the NODDI model is a major improvement over DTI, all three models assume a single dominant orientation of diffusion per voxel, which does not hold true in the majority of voxels which include healthy brain tissue (Jeurissen et al., 2013). It is also unlikely to hold true in UBOs. Directional estimates such as AD and RD should therefore be interpreted with care, as the directions they describe may not represent directions parallel and perpendicular to axons, respectively. Furthermore, NDI and ODI are designed to quantify the property of the tissue compartment contained within each voxel while eliminating the contamination from free water. An unavoidable issue arises when a voxel is predominantly free water. In such cases, the estimates of NDI and ODI, although they can still be computed numerically, are meaningless or cannot be determined accurately. To take this into account, for the analysis of NDI and ODI we only considered voxels for which FISO < 0.8.

As myelin water mapping from MRI data is a relatively recent technique, the analysis is continuously evolving and there are a number of ways to obtain MWF from MET2 or from other techniques such as mcDESPOT (Deoni et al., 2008) or from T2* decay (Hwang et al., 2010; Lenz et al., 2012). These different models, data acquisition and post-processing strategies will influence the estimated MWF. For example, acquisition parameters such as ?TE or TR may influence the results. While the ?TE used in this study allows estimation of the MWF, to obtain the exact position of the myelin peak would require shorter echo spacing. It is also known that shortening TR may increase the estimation of MWF (Kalantari et al., 2013). Our study had a shorter TR compared to other studies. Although the influence on results from within-subject comparative studies like ours may be limited, this may have contributed to overestimated MWF values in our sample. Similarly, the choice of integration window used to differentiate the myelin water peak from the intracellular water peak is somewhat arbitrary within an accepted range, and this will also affect MWF estimation. To rule out the effect of integration window choice on our results (10–35 ms for myelin water and 35–220 ms for IEW) we repeated the analysis using ranges that may be found in other studies (10–40 ms, 15–35 ms, 15–40 ms for myelin water and 40–220 ms, 35–200 ms, 40–200 ms for IEW). Although the estimated MWF did change according to integration window, this did not change the outcome of the statistical analysis. Nevertheless, it is important to note that MWF gives an indication of myelin content but not an exact quantification, and there is no consensus on the optimal acquisition or post-processing strategies to apply.

For these reasons, the imaging techniques used in this study will always lack the sensitivity and specificity of ex-vivo histological analysis. Nevertheless, in vivo studies like ours, although imperfect, provide data and insight that are simply not possible with histological analysis.

5. Conclusion

We have presented findings from the first multi-modal MET2, DTI, DKI and NODDI study of UBOs in NF1 patients. Results suggest that the NF1 related T2 hyperintensities (UBOs) can be attributed to intracellular water obtaining extracellular-like properties, causing increased average T2 time but stable intra- and extracellular water pool fractions.

The findings in this initial exploratory study support the hypothesis of intramyelinic vacuolization, in the absence of demyelination or axonal damage.

Combining advanced diffusion models with multi-exponential T2 relaxation has proven useful in characterizing UBOs and therefore may be beneficial for investigating the microstructural basis of T2 hyperintensities in other pathologies and in normal ageing.

Conflicts of interest

The authors declare that they have no conflict of interest.

Acknowledgments

The authors would like to thank and acknowledge Thomas Prasloski and colleagues at the UBC MRI Research Centre, for assisting with analysis of multi-echo data.

Footnotes

1

A hamartoma is tissue at its correct physiological site, growing in a disorganized manner, forming a focal but benign malformation. It consists of the same tissue elements as the tissue it resides in.

2

A heterotopia is ectopic tissue (i.e. not at its correct physiological site), co-existing with tissue it resides in.

3

http://www.nitrc.org/projects/noddi_toolbox; see Supplementary material SM1 for further information about these parameters.

Appendix A. Supplementary material

Supplementary material associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.nicl.2014.04.005.

Appendix A. Supplementary materials

List of parameters

mmc1.pdf (225.5KB, pdf)

T2 distributions

mmc2.pdf (668.9KB, pdf)

References

  1. Alkan A., Sigirci A., Kutlu R., Ozcan H., Erdem G., Aslan M. Neurofibromatosis type 1: diffusion weighted imaging findings of brain. European Journal of Radiology. 2005;56(2):229–234. doi: 10.1016/j.ejrad.2005.05.008. 15963674 [Comparative Study] [DOI] [PubMed] [Google Scholar]
  2. Anderson P.J., Leuzzi V. White matter pathology in phenylketonuria. Molecular Genetics and Metabolism. 2010;99(Suppl. 1):S3–S9. doi: 10.1016/j.ymgme.2009.10.005. 20123467 [Review] [DOI] [PubMed] [Google Scholar]
  3. Armspach J.P., Gounot D., Rumbach L., Chambron J. In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magnetic Resonance Imaging. 1991;9(1):107–113. doi: 10.1016/0730-725x(91)90104-t. 2056848 [DOI] [PubMed] [Google Scholar]
  4. Avants B.B., Epstein C.L., Grossman M., Gee J.C. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Medical Image Analysis. 2008;12(1):26–41. doi: 10.1016/j.media.2007.06.004. 17659998 [Research Support, N.I.H., Extramural] [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barnes D., McDonald W.I., Johnson G., Tofts P.S., Landon D.N. Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. Journal of Neurology, Neurosurgery, and Psychiatry. 1987;50(2):125–133. doi: 10.1136/jnnp.50.2.125. 3572428 [Research Support, Non-U.S. Gov't] [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Basser P.J., Mattiello J., LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. Journal of Magnetic Resonance. Series B. 1994;103(3):247–254. doi: 10.1006/jmrb.1994.1037. 8019776 [DOI] [PubMed] [Google Scholar]
  7. Basser P.J., Mattiello J., LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophysical Journal. 1994;66(1):259–267. doi: 10.1016/S0006-3495(94)80775-1. 8130344 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Basser P.J. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR in Biomedicine. 1995;8(7–8):333–344. doi: 10.1002/nbm.1940080707. 8739270 [Review] [DOI] [PubMed] [Google Scholar]
  9. Bognanno J.R., Edwards M.K., Lee T.A., Dunn D.W., Roos K.L., Klatte E.C. Cranial MR imaging in neurofibromatosis. AJR. American Journal of Roentgenology. 1988;151(2):381–388. doi: 10.2214/ajr.151.2.381. 3134807 [DOI] [PubMed] [Google Scholar]
  10. Braffman B.H., Bilaniuk L.T., Zimmerman R.A. The central nervous system manifestations of the phakomatoses on MR. Radiologic Clinics of North America. 1988;26(4):773–800. 3132730 [Review] [PubMed] [Google Scholar]
  11. Cutting L.E., Koth C.W., Burnette C.P., Abrams M.T., Kaufmann W.E., Denckla M.B. Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1. Journal of Child Neurology. 2000;15(3):157–160. doi: 10.1177/088307380001500303. 10757470 [Research Support, U.S. Gov't, P.H.S.] [DOI] [PubMed] [Google Scholar]
  12. Deoni S.C.L, Rutt B.K, Arun T., Pierpaoli C., Jones D.K. Gleaning multicomponent T1 and T2 information from steady-state imaging data. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2008;60(6):1372–1387. doi: 10.1002/mrm.21704. [DOI] [PubMed] [Google Scholar]
  13. Dezortova M., Hajek M., Tintera J., Hejcmanova L., Sykova E. MR in phenylketonuria-related brain lesions. Acta Radiologica. 2001;42(5):459–466. doi: 10.1080/028418501127347179. 11552882 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  14. DiPaolo D.P., Zimmerman R.A., Rorke L.B., Zackai E.H., Bilaniuk L.T., Yachnis A.T. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology. 1995;195(3):721–724. doi: 10.1148/radiology.195.3.7754001. 7754001 [Case reports] [DOI] [PubMed] [Google Scholar]
  15. Eastwood J.D., Fiorella D.J., MacFall J.F., Delong D.M., Provenzale J.M., Greenwood R.S. Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1. Radiology. 2001;219(2):354–358. doi: 10.1148/radiology.219.2.r01ap25354. 11323456 [Research Support, U.S. Gov't, P.H.S.] [DOI] [PubMed] [Google Scholar]
  16. Evans D.G., Howard E., Giblin C., Clancy T., Spencer H., Huson S.M. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. American Journal of Medical Genetics. Part A. 2010;152A(2):327–332. doi: 10.1002/ajmg.a.33139. 20082463 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  17. Feldmann R., Schuierer G., Wessel A., Neveling N., Weglage J. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1. Acta Paediatrica (Oslo, Norway: 1992) 2010;99(11):1657–1660. doi: 10.1111/j.1651-2227.2010.01923.x. 21039823 [DOI] [PubMed] [Google Scholar]
  18. Ferraz-Filho J.R., da Rocha A.J., Muniz M.P., Souza A.S., Goloni-Bertollo E.M., Pavarino-Bertelli E.C. Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities. Pediatric Radiology. 2012;42:449–454. doi: 10.1007/s00247-011-2274-1. 22033857 [DOI] [PubMed] [Google Scholar]
  19. Ferraz-Filho J.R., da Rocha J.A., Muniz M.P., Souza A.S., Goloni-Bertollo E.M., Pavarino-Bertelli E.C. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images. European Journal of Paediatric Neurology: EJPN: Official Journal of the European Paediatric Neurology Society. 2012;16(1):42–47. doi: 10.1016/j.ejpn.2011.10.002. [DOI] [PubMed] [Google Scholar]
  20. Filippi C.G., Bos A., Nickerson J.P., Salmela M.B., Koski C.J., Cauley K.A. Magnetic resonance diffusion tensor imaging (MRDTI) of the optic nerve and optic radiations at 3 T in children with neurofibromatosis type I (NF-1) Pediatric Radiology. 2012;42(2):168–174. doi: 10.1007/s00247-011-2216-y. 21858653 [DOI] [PubMed] [Google Scholar]
  21. Friston K., Ashbumer J., Kiebel S., Nichols T.E., Penny W. Statistical Parametric Mapping: The Analysis of Functional Brain Images. Elsevier; 2007. [Google Scholar]
  22. Goh W.H., Khong P.L., Leung C.S., Wong V.C. T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function. Journal of Child Neurology. 2004;19(11):853–858. doi: 10.1177/08830738040190110201. 15658789 [DOI] [PubMed] [Google Scholar]
  23. Greenwood R.S., Tupler L.A., Whitt J.K., Buu A., Dombeck C.B., Harp A.G. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1. Archives of Neurology. 2005;62(12):1904–1908. doi: 10.1001/archneur.62.12.1904. 16344348 [Comparative Study Research Support, N.I.H., extramural] [DOI] [PubMed] [Google Scholar]
  24. Griffiths P.D., Blaser S., Mukonoweshuro W., Armstrong D., Milo-Mason G., Cheung S. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics. 1999;104(4):e49. doi: 10.1542/peds.104.4.e49. 10506274 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  25. Harkins K.D., Valentine W.M., Gochberg D.F., Does M.D. In-vivo multi-exponential T2, magnetization transfer and quantitative histology in a rat model of intramyelinic edema. NeuroImage: Clinical. 2013;2:810–817. doi: 10.1016/j.nicl.2013.06.007. 24179832 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hwang D., Kim D.H., Du Y.P. In vivo multi-slice mapping of myelin water content using T2* decay. NeuroImage. 2010;52(1):198–204. doi: 10.1016/j.neuroimage.2010.04.023. [DOI] [PubMed] [Google Scholar]
  27. Hyman S.L., Gill D.S., Shores E.A., Steinberg A., North K.N. Journal of Neurology, Neurosurgery, and Psychiatry. 2007;78(10):1088–1091. doi: 10.1136/jnnp.2006.108134. 17299016 [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.] [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hyman S.L., Shores A., North K.N. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology. 2005;65(7):1037–1044. doi: 10.1212/01.wnl.0000179303.72345.ce. 16217056 [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.] [DOI] [PubMed] [Google Scholar]
  29. Itoh T., Magnaldi S., White R.M., Denckla M.B., Hofman K., Naidu S. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR. American Journal of Neuroradiology. 1994;15(8):1513–1519. 7985572 [Research Support, U.S. Gov't, P.H.S.] [PMC free article] [PubMed] [Google Scholar]
  30. Jensen J.H., Helpern J.A. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR in Biomedicine. 2010;23(7):698–710. doi: 10.1002/nbm.1518. 20632416 [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review] [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Jeurissen B., Leemans A., Tournier J.D., Jones D.K., Sijbers J. Investigating the prevalence of complex fiber configurations in white matter tissue with diffusion magnetic resonance imaging. Human Brain Mapping. 2013;34(11):2747–2766. doi: 10.1002/hbm.22099. 22611035 [Research Support, Non-U.S. Gov't] [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kalantari S., Komeilizadeh N., Vavasour I., Sahebjavaher R., MacKay A. Variation of myelin water fraction as a function of TR. Proceedings of the International Society for Magnetic Resonance in Medicine; International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition, Salt Lake City, Utah, USA 21; 2013. p. 1226. [Google Scholar]
  33. Krab L.C., Aarsen F.K., de Goede-Bolder A., Catsman-Berrevoets C.E., Arts W.F., Moll H.A. Impact of neurofibromatosis type 1 on school performance. Journal of Child Neurology. 2008;23(9):1002–1010. doi: 10.1177/0883073808316366. 18827266 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  34. Laule C., Vavasour I.M., Kolind S.H., Li D.K., Traboulsee T.L., Moore G.R. Magnetic resonance imaging of myelin. Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 2007;4(3):460–484. doi: 10.1016/j.nurt.2007.05.004. [Research Support, Non-U.S. Gov't Review] [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Laule C., Vavasour I.M., Kolind S.H., Traboulsee A.L., Moore G.R., Li D.K. Long T2 water in multiple sclerosis: what else can we learn from multi-echo T2 relaxation? Journal of Neurology. 2007;254(11):1579–1587. doi: 10.1007/s00415-007-0595-7. 17762945 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  36. Laule C., Vavasour I.M., Madler B., Kolind S.H., Sirrs S.M., Brief E.E. MR evidence of long T2 water in pathological white matter. Journal of Magnetic Resonance Imaging: JMRI. 2007;26(4):1117–1121. doi: 10.1002/jmri.21132. 17896375 [DOI] [PubMed] [Google Scholar]
  37. Lenz C., Klarhöfer M., Scheffler K. Feasibility of in vivo myelin water imaging using 3D multigradient-echo pulse sequences. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2012;68(2):523–528. doi: 10.1002/mrm.23241. [DOI] [PubMed] [Google Scholar]
  38. Le Bihan D., Breton E., Lallemand D., Grenier P., Cabanis E., Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161(2):401–407. doi: 10.1148/radiology.161.2.3763909. 3763909 [DOI] [PubMed] [Google Scholar]
  39. Leemans, A., ExploreDTI: A graphical toolbox for processing, analyzing, and visualizing diffusion MR data. in: Proceedings of the International Society for Magnetic Resonance in Medicine, 17 (2009). International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition, Honolulu, pp. 3537
  40. Leemans A., Jones D.K. The B-matrix must be rotated when correcting for subject motion in DTI data. Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2009;61(6):1336–1349. doi: 10.1002/mrm.21890. 19319973 [DOI] [PubMed] [Google Scholar]
  41. Leuzzi V., Tosetti M., Montanaro D., Carducci C., Artiola C., Antonozzi I. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study. Journal of Inherited Metabolic Disease. 2007;30(2):209–216. doi: 10.1007/s10545-006-0399-4. 17245558 [DOI] [PubMed] [Google Scholar]
  42. MacKay A., Laule C., Vavasour I., Bjarnason T., Kolind S., Madler B. Insights into brain microstructure from the T2 distribution. Magnetic Resonance Imaging. 2006;24(4):515–525. doi: 10.1016/j.mri.2005.12.037. 16677958 [DOI] [PubMed] [Google Scholar]
  43. MacKay A., Whittall K., Adler J., Li D., Paty D., Graeb D. In vivo visualization of myelin water in brain by magnetic resonance. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 1994;31(6):673–677. doi: 10.1002/mrm.1910310614. 8057820 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  44. Maedler, B., MacKay, A. (2007), Towards Whole Brain Myelin Imaging. Paper Presented at the International Society for Magnetic Resonance in Medicine, Berlin, Germany.
  45. Margariti P.N., Blekas K., Katzioti F.G., Zikou A.K., Tzoufi M., Argyropoulou M.I. Magnetization transfer ratio and volumetric analysis of the brain in macrocephalic patients with neurofibromatosis type 1. European Radiology. 2007;17(2):433–438. doi: 10.1007/s00330-006-0323-1. 16733674 [DOI] [PubMed] [Google Scholar]
  46. Mizukoshi W., Kozawa E., Kuramochi A., Uchino A., Kimura F. Quantitative assessment of water diffusion changes in brains of children with neurofibromatosis type I using apparent diffusion coefficient. Neuroradiology Journal. 2009;21(6):839–843. doi: 10.1177/197140090802100615. 24257055 [DOI] [PubMed] [Google Scholar]
  47. Moore B.D., Slopis J.M., Schomer D., Jackson E.F., Levy B.M. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology. 1996;46(6):1660–1668. doi: 10.1212/wnl.46.6.1660. 8649566 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  48. Moore B.D., 3rd, Slopis J.M., Jackson E.F., De Winter A.E., Leeds N.E. Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status. Neurology. 2000;54(4):914–920. doi: 10.1212/wnl.54.4.914. 10690986 [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.] [DOI] [PubMed] [Google Scholar]
  49. Phillips M.D., McGraw P., Lowe M.J., Mathews V.P., Hainline B.E. Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. AJNR. American Journal of Neuroradiology. 2001;22(8):1583–1586. 11559511 [Case reports] [PMC free article] [PubMed] [Google Scholar]
  50. Piscitelli O., Digilio M.C., Capolino R., Longo D., Di Ciommo V. Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning. Developmental Medicine and Child Neurology. 2012;54(1):49–51. doi: 10.1111/j.1469-8749.2011.04139.x. 22107256 [Letter Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  51. Poot D.H., den Dekker A.J., Achten E., Verhoye M., Sijbers J. Optimal experimental design for diffusion kurtosis imaging. IEEE Transactions on Medical Imaging. 2010;29(3):819–829. doi: 10.1109/TMI.2009.2037915. 20199917 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  52. Prasloski T., Madler B., Xiang Q.S., MacKay A., Jones C. Applications of stimulated echo correction to multicomponent T2 analysis. Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2012;67(6):1803–1814. doi: 10.1002/mrm.23157. 22012743 [DOI] [PubMed] [Google Scholar]
  53. Prasloski T., Rauscher A., MacKay A.L., Hodgson M., Vavasour I.M., Laule C. Rapid whole cerebrum myelin water imaging using a 3D GRASE sequence. Neuroimage. 2012;63(1):533–539. doi: 10.1016/j.neuroimage.2012.06.064. 22776448 [Research Support, Non-U.S. Gov't]. [DOI] [PubMed] [Google Scholar]
  54. Sirrs S.M., Laule C., Madler B., Brief E.E., Tahir S.A., Bishop C. Normal-appearing white matter in patients with phenylketonuria: water content, myelin water fraction, and metabolite concentrations. Radiology. 2007;242(1):236–243. doi: 10.1148/radiol.2421051758. 17185670 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  55. Smirniotopoulos J.G., Murphy F.M. The phakomatoses. AJNR. American Journal of Neuroradiology. 1992;13(2):725–746. 1566725 [Review] [PMC free article] [PubMed] [Google Scholar]
  56. Stanisz G.J., Webb S., Munro C.A., Pun T., Midha R. MR properties of excised neural tissue following experimentally induced inflammation. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2004;51(3):473–479. doi: 10.1002/mrm.20008. [Comparative Study research support, non-U .S. Gov't] [DOI] [PubMed] [Google Scholar]
  57. Steen R.G., Taylor J.S., Langston J.W., Glass J.O., Brewer V.R., Reddick W.E. Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities. AJNR. American Journal of Neuroradiology. 2001;22(5):810–817. 11337320 [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.] [PMC free article] [PubMed] [Google Scholar]
  58. Tognini G., Ferrozzi F., Garlaschi G., Piazza P., Patti A., Virdis R. Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1. Journal of Computer Assisted Tomography. 2005;29(3):298–304. doi: 10.1097/01.rct.0000162406.71300.b7. 15891494 [DOI] [PubMed] [Google Scholar]
  59. van Engelen S.J., Krab L.C., Moll H.A., de Goede-Bolder A., Pluijm S.M., Catsman-Berrevoets C.E. Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging. AJNR. American Journal of Neuroradiology. 2008;29(4):816–822. doi: 10.3174/ajnr.A0921. 18339726 [Research Support, Non-U.S. Gov't] [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Van Es S., North K.N., McHugh K., De Silva M. MRI findings in children with neurofibromatosis type 1: a prospective study. Pediatric Radiology. 1996;26(7):478–487. doi: 10.1007/BF01377205. 8662066 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  61. Vavasour I.M., Laule C., Li D.K., Traboulsee A.L., MacKay A.L. Journal of Magnetic Resonance Imaging: JMRI. 2011;33(3):713–718. doi: 10.1002/jmri.22441. 21563257 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  62. Vermathen P., Robert-Tissot L., Pietz J., Lutz T., Boesch C., Kreis R. Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2007;58(6):1145–1156. doi: 10.1002/mrm.21422. 18046700 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  63. Webb S., Munro C.A., Midha R., Stanisz G.J. Is multicomponent T2 a good measure of myelin content in peripheral nerve? Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2003;49(4):638–645. doi: 10.1002/mrm.10411. 12652534 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  64. Whittall K.P., MacKay A.L., Graeb D.A., Nugent R.A., Li D.K., Paty D.W. In vivo measurement of T2 distributions and water contents in normal human brain. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 1997;37(1):34–43. doi: 10.1002/mrm.1910370107. 8978630 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]
  65. Whittall K.P., Mackay A.L. Quantitative interpretation of NMR relaxation data. Journal of Magnetic Resonance. 1989;84(1):134–152. [Google Scholar]
  66. Zamboni S.L., Loenneker T., Boltshauser E., Martin E., Il'yasov K.A. Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1. AJNR. American Journal of Neuroradiology. 2007;28(4):773–776. 17416837 [PMC free article] [PubMed] [Google Scholar]
  67. Zhang H., Schneider T., Wheeler-Kingshott C.A., Alexander D.C. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage. 2012;61(4):1000–1016. doi: 10.1016/j.neuroimage.2012.03.072. 22484410 [Research Support, Non-U.S. Gov't] [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

List of parameters

mmc1.pdf (225.5KB, pdf)

T2 distributions

mmc2.pdf (668.9KB, pdf)

Articles from NeuroImage : Clinical are provided here courtesy of Elsevier

RESOURCES